XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Shareholders' Equity (Tables)
3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Summary of Company’s Common Stock The following is a summary of the Company’s common stock at March 31, 2019 and December 31, 2018.

 

 

March 31,

2019

 

 

December 31,

2018

 

Common stock authorized

 

 

200,000,000

 

 

 

200,000,000

 

Common stock outstanding

 

 

35,830,240

 

 

 

35,146,096

 

Company's Shares of Common Stock Reserved for Issuance

The Company’s shares of common stock reserved for issuance as of March 31, 2019 and December 31, 2018 were as follows:

 

 

 

March 31,

2019

 

 

December 31,

2018

 

Warrants acquired in merger

 

 

750,840

 

 

 

750,840

 

Warrants converted pursuant to merger

 

 

72,869

 

 

 

72,869

 

April 2017 SVB Warrants

 

 

24,725

 

 

 

24,725

 

June 2017 SVB Warrants

 

 

41,736

 

 

 

41,736

 

December 2018 SVB Warrants

 

 

11,332

 

 

 

11,332

 

Pre-funded warrants

 

 

775,000

 

 

 

775,000

 

Stock options outstanding

 

 

3,133,827

 

 

 

3,077,264

 

Issued and nonvested RSU's

 

 

143,125

 

 

 

156,250

 

Total shares reserved

 

 

4,953,454

 

 

 

4,910,016

 

 

Summary of Outstanding Warrants for Company's Common Stock

The following table summarizes the outstanding warrants for the Company’s common stock as of March 31, 2019:

 

Shares Underlying

Outstanding Warrants

 

 

Exercise Price

 

 

Expiration Date

 

314,446

 

 

$

52.50

 

 

November 2019

 

32,467

 

 

$

7.00

 

 

August 2020

 

403,927

 

 

$

29.40

 

 

February 2021

 

72,869

 

 

$

8.98

 

 

June 2021

 

775,000

 

 

$

0.01

 

 

October 2024

 

24,725

 

 

$

9.10

 

 

April 2027

 

41,736

 

 

$

5.39

 

 

June 2027

 

11,332

 

 

$

8.824

 

 

December 2028

 

1,676,502